Niki BiosolutionsNIKI
13F holders, Q1 2024 (March 31)5holders
$9.49avg. 13F price*
At the end of Q1 2024, 5 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings. The largest holders were Geode Capital Management, LLC ($374K), Murchinson Ltd. ($133K) and Morgan Stanley ($31K).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q1 2024)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $148K |
| Exits | 0 | $0 |
Ownership 5 holders
| Geode Capital Management, LLC | 0.00% | Add +2.3% | 39,427 | $374K |
| Murchinson Ltd. | 0.01% | New | 14,000 | $133K |
| Morgan Stanley | 0.00% | Reduce -37.3% | 3,290 | $31K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,560 | $15K |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $9 |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.